| Cell line name |
6T-CEM |
| Synonyms |
6-T CEM |
| Accession |
CVCL_6869 |
| Resource Identification Initiative |
To cite this cell line use: 6T-CEM (RRID:CVCL_6869) |
| Comments |
Group: Patented cell line. Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8296. Population: Caucasian. Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. Cell type: T-cell; CL=CL_0000084. |
| Sequence variations |
- Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
- Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
|
| Disease |
Childhood T acute lymphoblastic leukemia (NCIt: C7953) Precursor T-cell acute lymphoblastic leukemia (ORDO: Orphanet_99861) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Hierarchy |
Parent: CVCL_0207 (CCRF-CEM) Children:
|
| Sex of cell |
Female |
| Age at sampling |
3Y11M |
| Category |
Cancer cell line |
| STR profile |
Source(s): ATCC=CRL-8296; CCRID=3101HUMTCHu2; CLS=305132
Markers:| Amelogenin | X |
| CSF1PO | 10,11 |
| D2S1338 | 24 |
| D3S1358 | 14,15 (CCRID=3101HUMTCHu2) 15 (CLS=305132) |
| D5S818 | 11,12,13 (ATCC=CRL-8296) 11,13 (CCRID=3101HUMTCHu2; CLS=305132) |
| D6S1043 | 11,14 |
| D7S820 | 9,14 |
| D8S1179 | 13 |
| D12S391 | 17,18,20,21 |
| D13S317 | 11,12 |
| D16S539 | 10,13 |
| D18S51 | 13,18 |
| D19S433 | 14,15 |
| D21S11 | 31,33.2 |
| FGA | 23,24 |
| Penta D | 11 |
| Penta E | 5,14 |
| TH01 | 6,7 |
| TPOX | 8 |
| vWA | 17,19 |
Run an STR similarity search on this cell line |
| Publications | Patent=US4705687 Catherine Y. Lau; Treatment of autoimmune diseases such as rheumatoid arthritis with suppressor factor. Patent number US4705687, 10-Nov-1987 Patent=US4728614 Catherine Y. Lau; Mutant human T cell line producing immunosuppressive factor and method for obtaining such mutants. Patent number US4728614, 01-Mar-1988 |
| Cross-references |
| Cell line collections (Providers) |
ATCC; CRL-8296 - Discontinued
CLS; 305132
|
| Cell line databases/resources |
cancercelllines; CVCL_6869
CCRID; 3101HUMTCHu2
|
| Biological sample resources |
BioSample; SAMN03471201
|
| Encyclopedic resources |
Wikidata; Q54604612
|
| Entry history |
| Entry creation | 04-Apr-2012 |
| Last entry update | 10-Apr-2025 |
| Version number | 32 |
|---|